Trainee Pearls podcast

#18 Jurjen Versluis: Transplant for high-risk MDS

29/10/2023
0:00
20:34
Reculer de 15 secondes
Avancer de 15 secondes

Allogeneic hematopoietic cell transplantation (HCT) in patients with myelodysplastic syndrome (MDS) improves overall survival. The authors evaluated the impact of MDS genetics on the benefit of HCT in a biological assignment (donor v no donor) study. https://pubmed.ncbi.nlm.nih.gov/37607457/ ALSO AS VIDEO ON https://youtu.be/JbHS_-2sJQc CONNECT WITH US https://twitter.com/TheEBMT_Trainee https://www.ebmt.org/trainee-committee https://twitter.com/CarmeloGurnari


D'autres épisodes de "Trainee Pearls"